Oral Arguments of the Federal Circuit’s Precedential Opinions of 2023 (Part 2)

 Opinion LinkOral Argument Link
   
21ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC. [OPINION]  Arbutus Biopharma Corporation v. ModernaTX, Inc.  
22HEALTHIER CHOICES MANAGEMENT CORP. v. PHILIP MORRIS USA, INC. [OPINION]  Healthier Choices Management Corp. v. Philip Morris USA, Inc.  
23SANDERLING MANAGEMENT LTD. v. SNAP INC. [OPINION]  Sanderling Management Ltd. v. Snap Inc.  
24SEQUOIA TECHNOLOGY, LLC v. DELL, INC. [OPINION]  Sequoia Technology, LLC v. Dell, Inc  
25UCB, INC. v. ACTAVIS LABORATORIES UT, INC. [OPINION]  UCB, Inc. v. Actavis Laboratories UT, Inc.  
26AMGEN INC. v. SANDOZ INC. [OPINION]  Amgen Inc. v. Sandoz Inc.  
27FS.COM INC. v. ITC [OPINION]  FS.com Inc. v. ITC  
28HIP, INC. v. HORMEL FOODS CORPORATION [OPINION]  HIP, Inc. v. Hormel Foods Corporation  
29UNITED CANNABIS CORPORATION v. PURE HEMP COLLECTIVE INC. [OPINION]  United Cannabis Corporation v. Pure Hemp Collective Inc.  
30SANOFI-AVENTIS DEUTSCHLAND GMBH v. MYLAN PHARMACEUTICALS INC. [OPINION]  Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.  
31BOT M8 LLC v. SONY INTERACTIVE ENTERTAINMENT LLC [OPINION]  Bot M8 LLC v. Sony Interactive Entertainment LLC  
32ONESUBSEA IP UK LIMITED v. FMC TECHNOLOGIES, INC. [OPINION]  OneSubsea IP UK Limited v. FMC Technologies, Inc.  
33Amgen Inc. v. Sanofi   US Supreme CourtAmgen Inc. v. Sanofi    
34MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. [OPINION]  Medtronic, Inc. v. Teleflex Innovations S.A.R.L.  
35MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. [OPINION]  Medtronic, Inc. v. Teleflex Innovations S.A.R.L.  
36YITA LLC v. MACNEIL IP LLC [OPINION]  Yita LLC v. MacNeil IP LLC  
37BLUE GENTIAN, LLC v. TRISTAR PRODUCTS, INC. [OPINION]  Blue Gentian, LLC v. Tristar Products, Inc.  
38PARUS HOLDINGS, INC. v. GOOGLE LLC [OPINION]  Parus Holdings Inc. v. Google LLC  
39In Re COUVARAS [OPINION]  In Re Couvaras  
40MEDYTOX, INC. v. GALDERMA S.A. [OPINION]  Medytox, Inc. v. Galderma S.A.  

This entry was posted on Thursday, October 31st, 2024 at 7:14 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

Comments are closed.